{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-011974","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.515314+00:00","generated_at":"2026-05-31T04:30:09.030288+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pharma-Bio Serv Q3 revenue falls to $2.4M, swings to net loss of $0.3M","bullets":["Q3 revenue $2.4M, down ~$2.2M (48%) from $4.6M in same quarter last year.","Net loss of $0.3M compared to net income of $0.5M in Q3 last year.","Nine-month revenue $7.2M (down $6.2M); net loss $0.8M vs net income $1.4M.","CEO cites challenging investment environment; investing in tech tools to return to profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-011974","json":"https://secwatch.observer/filing/0001654954-24-011974.json","markdown":"https://secwatch.observer/filing/0001654954-24-011974.md","text":"https://secwatch.observer/filing/0001654954-24-011974.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/0001654954-24-011974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:30:09.030288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}